Abstract
Management of Campanacci Grade III Giant Cell Tumors of bone (GCT) is challenging. Although selected cases of Grade III GCTs can still be managed with intralesional extended curettage, wide excision of the lesion is usually recommended when there is extensive cortical destruction. This study describes the outcome of ‘longitudinal sandwich technique’ for extended curettage of Grade III GCTs with more than 50% cortical destruction. Here, the deficiency of cortex was made up for by using bone graft/graft substitute, used alongside cement placed in a longitudinal fashion. Twelve patients operated with this technique between Jan 2012 and Jan 2018 were reviewed. Majority of the lesions involved the lower limbs. Bone graft was used in eight whereas commercial bone graft substitute was used in the remaining four, along with bone cement in all. On follow-up ranging from 38 to 84 months (median follow-up 59 months), there were 4 local recurrences (33.33%). All recurrences were managed successfully with repeat surgery without the need for bony resection. Mean MSTS score during the last follow-up was 25.08 ± 2.31 and all patients were disease-free during the last follow-up. ‘Longitudinal sandwich technique’ helps to expand the indications of extended curettage even for aggressive Grade III GCTs, with satisfactory outcomes.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13193-022-01545-3/MediaObjects/13193_2022_1545_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13193-022-01545-3/MediaObjects/13193_2022_1545_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13193-022-01545-3/MediaObjects/13193_2022_1545_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13193-022-01545-3/MediaObjects/13193_2022_1545_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13193-022-01545-3/MediaObjects/13193_2022_1545_Fig5_HTML.png)
Similar content being viewed by others
Data Availability
Available from corresponding author on reasonable request.
References
Sobti A, Agrawal P, Agarwala S, Agarwal M (2016) Giant cell tumor of bone - an overview. Arch Bone Jt Surg 4(1):2–9
Zheng K, Yu XC, Hu YC, Wang Z, Wu SJ, Ye ZM, Giant Cell Tumor Group of China (GTOC), (2017) How to fill the cavity after curettage of giant cell tumors around the knee? A multicenter analysis. Chin Med J (Engl) 130 (21) 2541–2546
Radev BR, Kase JA, Askew MJ, Weiner SD (2009) Potential for thermal damage to articular cartilage by PMMA reconstruction of a bone cavity following tumor excision: a finite element study. J Biomech 42(8):1120–1126
Kundu ZS, Gogna P, Singla R, Sangwan SS, Kamboj P, Goyal S (2015) Joint salvage using sandwich technique for giant cell tumors around knee. J Knee Surg 28(2):157–164
Saibaba B, Chouhan DK, Kumar V, Dhillon MS, Rajoli SR (2014) Curettage and reconstruction by the sandwich technique for giant cell tumours around the knee. J Orthop Surg (Hong Kong) 22(3):351–355
Lackman RD, Crawford EA, King JJ, Ogilvie CM (2009) Conservative treatment of Campanacci grade III proximal humerus giant cell tumors. Clin Orthop Relat Res 467(5):1355–1359
Kang L, Manoso MW, Boland PJ, Healey JH, Athanasian EA (2010) Features of grade 3 giant cell tumors of the distal radius associated with successful intralesional treatment. J Hand Surg Am 35(11):1850–1857
Ward WG Sr, Li G 3rd (2002) Customized treatment algorithm for giant cell tumor of bone: report of a series. Clin Orthop Relat Res 397:259–270
Cheng CY, Shih HN, Hsu KY, Hsu RW (2001) Treatment of giant cell tumor of the distal radius. Clin Orthop Relat Res 383:221–228
Liu YP, Li KH, Sun BH (2012) Which treatment is the best for giant cell tumors of the distal radius? A meta-analysis Clin Orthop Relat Res 470(10):2886–2894
Eckardt JJ, Grogan TJ (1986) Giant cell tumor of bone. Clin Orthop Relat Res 204:45–58
Labs K, Perka C, Schmidt RG (2001) Treatment of stages 2 and 3 giant-cell tumor. Arch Orthop Trauma Surg 121(1–2):83–86
Klenke FM, Wenger DE, Inwards CY, Rose PS, Sim FH (2011) Giant cell tumor of bone: risk factors for recurrence. Clin Orthop Relat Res 469(2):591–599
Wang HC, Chien SH, Lin GT (2005) Management of grade III giant cell tumors of bones. J Surg Oncol 92(1):46–51
Blackley HR, Wunder JS, Davis AM, White LM, Kandel R, Bell RS (1999) Treatment of giant-cell tumors of long bones with curettage and bone-grafting. J Bone Joint Surg Am 81(6):811–820
Mankin HJ, Hornicek FJ (2005) Treatment of giant cell tumors with allograft transplants: a 30-year study. Clin Orthop Relat Res 439:144–150
Salunke AA, Pathak S, Shah J, Pandit J, Naneria V (2018) Wide resection versus curettage in giant cell tumor with pathological fracture? A systematic review and meta-analysis. J Clin Orthop Trauma 9(Suppl 1):S15–S18
Puri A, Gulia A, Hegde P, Verma V, Rekhi B (2019) Neoadjuvant denosumab: its role and results in operable cases of giant cell tumour of bone. Bone Joint J 101-B(2):170–177
Tse LF, Wong KC, Kumta SM, Huang L, Chow TC, Griffith JF (2008) Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case-control study. Bone 42(1):68–73
Henderson ER, Groundland JS, Pala E et al (2011) Failure mode classification for tumor endoprostheses: retrospective review of five institutions and a literature review. J Bone Joint Surg Am 93(5):418–429
Pala E, Trovarelli G, Calabrò T, Angelini A, Abati CN, Ruggieri P (2015) Survival of modern knee tumor megaprostheses: failures, functional results, and a comparative statistical analysis. Clin Orthop Relat Res 473(3):891–899
Dahlin DC, Cupps RE, Johnson EW Jr (1970) Giant-cell tumor: a study of 195 cases. Cancer 25(5):1061–1070
Ghert MA, Rizzo M, Harrelson JM, Scully SP (2002) Giant-cell tumor of the appendicular skeleton. Clin Orthop Relat Res 400:201–210
Shi W, Indelicato DJ, Reith J et al (2013) Radiotherapy in the management of giant cell tumor of bone. Am J Clin Oncol 36(505–508):119
Bhatia S, Miszczyk L, Roelandts M et al (2011) Radiotherapy for marginally resected, unresectable or recurrent giant cell tumor of the bone: a rare cancer network study. Rare Tumors 3:e48
Puri A, Gupta SM, Gulia A, Shetty N, Laskar S (2021) Giant cell tumors of the sacrum: is non-operative treatment effective? Eur Spine J 30(10):2881–2886
van der Heijden L, Dijkstra PD, van de Sande MA, Kroep JR, Nout RA, van Rijswijk CS, Bovée JV, Hogendoorn PC, Gelderblom H (2014) The clinical approach toward giant cell tumor of bone. Oncologist 19(5):550–561
Ibe IK, Alder KD, Henderson SE, Yu KE, Lee FY (2019) Excisional curettage of benign cystic lesions. JBJS Essent Surg Tech 9(3):e24
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Poudel, R.R., Tiwari, A., Jain, A. et al. Salvaging the Unsalvageable Giant Cell Tumors of Bone: The ‘Longitudinal Sandwich Technique’. Indian J Surg Oncol 13, 316–321 (2022). https://doi.org/10.1007/s13193-022-01545-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-022-01545-3